Financials data is unavailable for this security.
View more
Year on year Wai Chun Bio Technology Ltd had revenues fall -23.19% from 1.01bn to 773.65m, though the company grew net income from a loss of 21.55m to a smaller loss of 15.43m.
Gross margin | 7.25% |
---|---|
Net profit margin | -1.57% |
Operating margin | 2.28% |
Return on assets | -3.20% |
---|---|
Return on equity | -- |
Return on investment | -668.24% |
More ▼
Cash flow in HKDView more
In 2023, cash reserves at Wai Chun Bio Technology Ltd fell by 1.21m. However, the company earned 48.93m from its operations for a Cash Flow Margin of 6.32%. In addition the company used 28.14m on investing activities and also paid 21.46m in financing cash flows.
Cash flow per share | 0.0332 |
---|---|
Price/Cash flow per share | 2.24 |
Book value per share | -0.227 |
---|---|
Tangible book value per share | -0.227 |
More ▼
Balance sheet in HKDView more
Current ratio | 0.746 |
---|---|
Quick ratio | 0.5867 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 0.9195 |
More ▼